Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
31,628,609
-
Shares change
-
+3,592,190
-
Total reported value, excl. options
-
$1,962,983,846
-
Value change
-
+$227,346,470
-
Put/Call ratio
-
74%
-
Number of buys
-
89
-
Number of sells
-
35
-
Price
-
$62.09
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q1 2015
As of 31 Mar 2015 Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) had 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,628,609 shares of stock of the company.
Largest 10 holders included FMR LLC, Capital Research Global Investors, COLUMBIA WANGER ASSET MANAGEMENT LLC, TPG Group Holdings (SBS) Advisors, Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, MILLENNIUM MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP LLC, and Visium Asset Management, LP.
This table shows 126 institutional shareholders of the security as of 31 Mar 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.